Perth biotech Phylogica today announced positive test results from its drug delivery technology, but the news was not enough to sustain a rally in the company's shares, which have risen 33 per cent over the past week.

Perth biotech Phylogica today announced positive test results from its drug delivery technology, but the news was not enough to sustain a rally in the company's shares, which have risen 33 per cent over the past week.